Literature DB >> 17846326

Protein precoating of elastomeric tissue-engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells.

Virna L Sales1, George C Engelmayr, John A Johnson, Jin Gao, Yadong Wang, Michael S Sacks, John E Mayer.   

Abstract

BACKGROUND: Optimal cell sources and scaffold-cell interactions remain unanswered questions for tissue engineering of heart valves. We assessed the effect of different protein precoatings on a single scaffold type (elastomeric poly (glycerol sebacate)) with a single cell source (endothelial progenitor cells). METHODS AND
RESULTS: Elastomeric poly (glycerol sebacate) scaffolds were precoated with laminin, fibronectin, fibrin, collagen types I/III, or elastin. Characterized ovine peripheral blood endothelial progenitor cells were seeded onto scaffolds for 3 days followed by 14 days incubation. Endothelial progenitor cells were CD31+, vWF+, and alpha-SMA- before seeding confirmed by immunohistochemistry and immunoblotting. Both precoated and uncoated scaffolds demonstrated surface expression of CD31+ and vWF+, alpha-SMA+ cells and were found in the "interstitium" of the scaffold. Protein precoating of elastomeric poly (glycerol sebacate) scaffolds revealed significantly increased cellularity and altered the phenotypes of endothelial progenitor cells, which resulted in changes in cellular behavior and extracellular matrix production. Moreover, mechanical flexure testing demonstrated decreased effective stiffness of the seeded scaffolds compared with unseeded controls.
CONCLUSIONS: Scaffold precoating with extracellular matrix proteins can allow more precise "engineering" of cellular behavior in the development of tissue engineering of heart valves constructs by altering extracellular matrix production and cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846326     DOI: 10.1161/CIRCULATIONAHA.106.6806637

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  Metal mesh scaffold for tissue engineering of membranes.

Authors:  S Hamed Alavi; Arash Kheradvar
Journal:  Tissue Eng Part C Methods       Date:  2011-12-22       Impact factor: 3.056

2.  Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine.

Authors:  Brian D Plouffe; Tatiana Kniazeva; John E Mayer; Shashi K Murthy; Virna L Sales
Journal:  FASEB J       Date:  2009-06-01       Impact factor: 5.191

3.  Material-based deployment enhances efficacy of endothelial progenitor cells.

Authors:  Eduardo A Silva; Eun-Suk Kim; Hyun Joon Kong; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-15       Impact factor: 11.205

Review 4.  Tissue engineering on matrix: future of autologous tissue replacement.

Authors:  Benedikt Weber; Maximilian Y Emmert; Roman Schoenauer; Chad Brokopp; Laura Baumgartner; Simon P Hoerstrup
Journal:  Semin Immunopathol       Date:  2011-01-29       Impact factor: 9.623

Review 5.  Fundamentals and application of magnetic particles in cell isolation and enrichment: a review.

Authors:  Brian D Plouffe; Shashi K Murthy; Laura H Lewis
Journal:  Rep Prog Phys       Date:  2014-12-04

Review 6.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

7.  Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension.

Authors:  Georg Hansmann; Brian D Plouffe; Adam Hatch; Alexander von Gise; Hannes Sallmon; Roham T Zamanian; Shashi K Murthy
Journal:  J Mol Med (Berl)       Date:  2011-07-07       Impact factor: 4.599

8.  Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering.

Authors:  Nafiseh Masoumi; Aurélie Jean; Jeffrey T Zugates; Katherine L Johnson; George C Engelmayr
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

9.  The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.

Authors:  Sharan Ramaswamy; Danielle Gottlieb; George C Engelmayr; Elena Aikawa; David E Schmidt; Diana M Gaitan-Leon; Virna L Sales; John E Mayer; Michael S Sacks
Journal:  Biomaterials       Date:  2009-11-26       Impact factor: 12.479

10.  Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.

Authors:  Virna L Sales; Bret A Mettler; George C Engelmayr; Elena Aikawa; Joyce Bischoff; David P Martin; Alexis Exarhopoulos; Marsha A Moses; Frederick J Schoen; Michael S Sacks; John E Mayer
Journal:  Tissue Eng Part A       Date:  2010-01       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.